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More than half of the women treated for invasive breast cancer will face one or more long-term upper extremity (UE) impairments. 1 Lymphedema, pain, weakness, and limitations in shoulder range of motion (ROM) are linked to decreases in UE function and quality of life (QOL). 1Y5 Predictors of reductions in UE function after breast cancer treatment include older age, greater body mass index (BMI), having a mastectomy versus breast conserving surgery (BCS), having an axillary lymph node dissection (ALND), and receipt of radiation therapy and chemotherapy(CTX). 1, 6 Identificationof additionalpredictors, particularly modifiable preoperative predictors, could have a significant impact on recovery of function after breast cancer treatment.
Changes in UE function are evaluated by self-report and through assessments of ROM and strength. In a prospective study of 115 women with stage 0 to stage III breast cancer, 6 reductions in flexion and abduction ROM were found in 60% of the women 1 month after breast cancer surgery. Among the 10% of women whose ROM reductions persisted at 12 months, characteristics associated with these reductions included a higher number of positive lymph nodes, older age, and BMI greater than 25 kg/m 2 . In a study that evaluated the impact of early postoperative shoulder function on shoulder function at 12 months after treatment for stage I to stage IIB breast cancer, 1 external rotation and combined abductionYexternal rotation at 6 weeks were the strongest predictors of external rotation and combined abductionYexternal rotation at 12 months. Similarly, the degree of shoulder abduction at 6 weeks was an independent predictor of shoulder abduction at 12 months. Importantly, 24% of the women in this study had a clinically meaningful restriction in shoulder abduction ROM (ie, Q20 degrees) on their treated versus their untreated side at 12 months.
Upper extremity strength is commonly measured by assessment of grip strength. 7 Sagen et al. 8 found an 11% bilateral reduction in grip strength from preoperative levels to 2.5 years after surgery in women who had an ALND. In a prospective evaluation of changes in grip strength in women taking aromatase inhibitors or tamoxifen, 9 musculoskeletal pain complaints were increased and grip strength was decreased in both groups at 12 months.
However, no information is available on the trajectories of change in UE function after breast cancer treatment and the predictors of interindividual differences in these trajectories. Particularly missing is the impact of preoperative UE function (ie, shoulder ROM) on postoperative UE function. Identification of modifiable preoperative characteristics that can be targeted for early intervention, even before surgery, may minimize the occurrence and severity of treatmentrelated UE impairments. Therefore, the purposes of this prospective, longitudinal study were to evaluate for changes in UE function (ie, shoulder ROM, grip strength, and functional interference due to breast pain) in women during the first year after breast cancer treatment and to evaluate for demographic and clinical characteristics that predicted interindividual differences in these trajectories.
MATERIALS AND METHODS

Patients and Settings
This study is part of a larger prospective longitudinal study that evaluated for neuropathic pain and lymphedema in a sample of women who underwent breast cancer surgery. The methods for this study are described in detail elsewhere. 10Y13 Patients were recruited from breast care centers located in a comprehensive cancer center, 2 public hospitals, and 4 community practices. Patients were eligible to participate if they were adult women (older than 18 years) who would undergo unilateral breast cancer surgery on one breast; were able to read, write, and understand English; agreed to participate; and gave written informed consent. Patients were excluded if they
Disclosures:
This study was funded by grants from the National Cancer Institute (NCI, CA107091 and CA118658 
Editor's Note:
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal_s Web site (www.ajpmr.com).
were having bilateral breast cancer surgery or had distant metastases at the time of diagnosis. Of the 516 patients approached, 410 were enrolled (response rate, 79.5%), and 396 completed the study. The major reasons for refusal were too busy, overwhelmed with the cancer diagnosis, or insufficient time available to do the assessment before surgery.
Subjective Measures
The demographic questionnaire obtained information on age, marital status, education, ethnicity, employment status, living situation, activity level, and financial status. The Self-Administered Comorbidity Questionnaire was used to assess comorbidities. 14 15 The breast pain functional interference scale was adapted from the Brief Pain Inventory (BPI). 16 This valid and reliable scale was used to evaluate the extent to which breast pain interfered with the patient_s ability to function. 17, 18 In addition to the original 8 items on the BPI interference scale (ie, general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life, and sexual activity), 9 activities from the work of Tasmuth et al. 19, 20 were evaluated (ie, ability to sleep on the operated side, ability to touch the site, ability to reach out in front, ability to carry things, ability to get up from bed, ability to do handicrafts, ability to drive a car, ability to write, and ability to reach overhead). Patients were asked to evaluate the degree to which pain interfered with each of these activities during the past week, using a zero (does not interfere) to 10 (completely interferes) numeric rating scale (NRS). Scores on these 9 individual UE items were averaged to obtain a UE total interference score that ranged from zero to 10. Higher scores indicate greater interference with function.
Objective Measures
Active ROM was assessed using a goniometer and standardized procedures reported by Norkin and White. 21 Bilateral shoulder abduction and flexion were assessed with the patient supine. Two measurements were taken for each motion and a mean obtained. Grip strength was assessed using a Jamar hydraulic hand dynamometer (Patterson Medical, Bolingbrook, IL). Patients stood with the arm held down at their side and were instructed to squeeze with maximal effort. Three trials for each extremity were done, and a mean grip score was calculated. Body mass index was calculated from height and weight, which were assessed at enrollment and at each postoperative assessment.
Study Procedures
The study was approved by the Committee on Human Research at the University of California, San Francisco and by the institutional review boards at each of the study sites. During the patient_s preoperative visit, a clinician explained the study to the patient, determined the patient_s willingness to participate, and introduced the patient to the research nurse. The research nurse determined the patient_s eligibility. After providing written informed consent, patients completed the study questionnaires. The research nurse then performed the objective measurements. Disease and treatment information were abstracted from the patients_ medical records. The research nurse met with the patients either in their home or in the clinic at 1, 2, 3, 4, 5, 6, 8, 10, and 12 months after surgery. During each of the study visits, the patients completed the study questionnaires and had the objective measures assessed by the research nurse.
Data Analysis
Descriptive statistics and frequency distributions were generated for demographic and clinical characteristics using SPSS Statistics for Windows, version 22.0 (IBM Corporation, Armonk, NY). Comparisons of shoulder ROM and grip strength between the preoperative and 12-month assessments were done using paired t tests. Differences between ROM on the unaffected and affected sides were calculated to determine how many women had interlimb differences of 20 degrees or more at 12 months. This degree of change is associated with impairment in activities of daily living. 1, 22 Differences in proportions were evaluated using the McNemar test.
Hierarchical linear modeling (HLM), based on full maximum likelihood estimation, was done using the software developed by Raudenbush and Bryk. 23 With HLM, the repeated measures for ROM, grip strength, and breast pain interference scores are nested within individuals, and the analysis of change in these outcomes has 2 levels: within-person variability (level 1) and betweenpersons variability (level 2). 23 Separate HLM analyses were done to evaluate for changes over time in each outcome for the at-risk limb (ie, the arm on the operated side). Each HLM analysis proceeded www.ajpmr.com in 2 stages. First, within-person variability (level 1) in the outcome measure over time was examined. Four level 1 models were compared, which represented the following: (1) change over time (ie, time effect), (2) change at a constant rate (ie, linear time effect), (3) change at a rate that accelerates or decelerates over time (ie, quadratic effect), and (4) change in the pattern of acceleration/deceleration (ie, cubic effect). The level 1 model was constrained to be unconditional (ie, no predictors), and likelihood ratio tests were used to determine the best model.
The second stage of the HLM analysis examined interindividual differences (level 2) in the trajectories of each of the outcomes by modeling the individual change parameters (ie, intercept, linear, quadratic, and cubic) as a function of the proposed predictors. A list of predictors for each outcome can be found in online supplemental Tables S1 (http://links.lww.com/PHM/A190) and S2 (http://links.lww.com/PHM/A191). To improve estimation efficiency and construct a parsimonious model, exploratory level 2 analyses were done in which each potential predictor was assessed to see if it would result in a better-fitting model if it alone was added as a level 2 predictor. Predictors with a t value of 2.0 or less, which indicates a lack of a significant effect, were dropped from subsequent model testing. 23 All of the potentially significant predictors from the exploratory analyses were entered into the model to predict each individual change parameter. Only predictors that maintained a significant contribution in conjunction with other variables were retained in the final model. Statistical significance was set at P G 0.05. Once the significant predictors were identified, they were categorized for graphical display to illustrate their effects on the dependent variable. Continuous predictor variables were dichotomized using the convention of 1 standard deviation (SD) above and below the mean value for the study participants. The intercepts reflect the predicted mean values of the outcomes at the 1-month postoperative assessment, and the trajectories reflect the changes in the postoperative outcomes during the year after breast cancer surgery. In each of the figures, the preoperative value for the UE outcome is plotted as a dotted line across the 12 months of the study.
RESULTS
Patients_ Characteristics
Of the 396 women who completed the study, 64% were white, 89% were right handed, and 47% had their cancer on the side of their dominant limb. Eighty percent had BCS and 20% had a mastectomy. Forty-four percent of the women in this study had stage II disease or higher (Table 1 ).
Preoperative and 12-Month Postoperative Comparisons of ROM and Grip Strength
Comparisons between preoperative and 12-month postoperative values for shoulder ROM and for grip strength were performed bilaterally ( Table 2) . Mean shoulder flexion and abduction ROM of the affected limb were slightly lower at 12 months compared to preoperative levels.
However, 16.6% of the women had 20 degrees or greater restriction in shoulder abduction ROM on their affected side compared to their unaffected side at 12 months, compared to only 7.8% preoperatively (P G 0.001). Similarly, more women had 20 degrees or greater restriction of shoulder flexion at 12 months compared to preoperatively (4.0% versus 1.8%, respectively), although this difference did not reach statistical significance (P = 0.057).
Hierarchical Linear Modeling
The first stage of the HLM analysis was performed for each outcome to evaluate for changes over time in abduction, flexion, grip strength, and breast pain interference on the affected side over the 12-month postoperative period. Linear, quadratic, and cubic models were estimated. For each outcome, the final estimate of the fixed effects determined that a cubic model fit the data best (Tables 3  and 4 ). In the second phase of the HLM analyses, variability in the trajectories of change in each outcome based on specific demographic, clinical, and treatment characteristics were evaluated. Exploratory analyses were conducted with the predictors listed in the online supplemental Tables S1 and S2. Predictors that maintained a significant contribution in combination with the other variables were retained in the final models (Tables 3  and 4 ). Table 3 presents estimates of the unconditional cubic change model for shoulder abduction ROM. As Figure 1A depicts, the trajectory for abduction over the 12 months showed an increase from months 1 through 5, a modest decline between months 5 and 8, www.ajpmr.com Arm Function After Breast Cancer Treatment and then a gradual increase beginning at month 10 to the maximum predicted value at month 12. As the final model in Table 3 and Figures 1B through F shows, 5 variables predicted interindividual differences in the intercept for shoulder abduction ROM. Being nonwhite, having received neoadjuvant CTX, having a mastectomy versus BCS, having an ALND, and having poorer preoperative shoulder abduction were associated with greater reductions in shoulder abduction at the 1-month assessment.
Shoulder Abduction
Four variables that predicted interindividual differences in the trajectories of shoulder abduction ROM over the 12-month postoperative period were type of breast cancer surgery (Fig. 1D) , ALND (Fig. 1E) , lived alone at enrollment (Supplemental Figure 1A Women who lived alone demonstrated a greater improvement in abduction ROM to month 4, at which time a decline in ROM occurred to month 10. From months 10 to 12, their abduction improved and at month 12 was essentially the same as the women who did not live alone. Women who had a mastectomy versus BCS had greater reductions in ROM at month 1 that improved by months 5 to levels seen in the women with BCS. Although both groups demonstrated reductions in abduction between months 5 and 10, these reductions were greater in the women with mastectomy. Women who had an ALND demonstrated less abduction ROM than women who did not have an ALND. Both groups demonstrated gradual improvements between months 1 and 6, followed by a slight reduction between months 6 and 10, and then improvements to similar values by month 12. Whereas no differences in the 1-month values were found, the women who received adjuvant CTX demonstrated greater increases in shoulder abduction during the first 4 months. Between months 5 and 10, their abduction ROM declined and gradually improved by month 12 to levels seen in the women who did not receive adjuvant CTX. Table 3 presents the estimates of the unconditional cubic change model for shoulder flexion ROM. As Figure 2A shows, the trajectory for flexion over the 12 months showed an increase from months 1 through 5, a modest decline between months 5 and 8, followed by a gradual increase beginning at month 10 to the maximum predicted value at month 12.
Shoulder Flexion
As the final model in Table 3 and Figures 2B through F and 3A and B shows, 7 variables predicted interindividual differences in the intercept for shoulder flexion ROM. Fewer years of education, decreased participation in exercise preoperatively, receipt of neoadjuvant CTX, higher breast pain interference scores at enrollment, having an ALND, placement of a surgical drain, and having poorer preoperative shoulder flexion were associated with decreased shoulder flexion ROM at the 1-month assessment.
As Figures 3A and C through E show, the 4 variables that predicted interindividual differences in the trajectories of shoulder flexion ROM were lived alone, type of breast cancer surgery, placement of a surgical drain, and receipt of adjuvant CTX during the first year. The trajectories of shoulder flexion predicted by living alone and receipt of CTX are similar to those for shoulder abduction. Women with mastectomy and women with BCS had similar shoulder flexion at 1 month, but the women with mastectomy had greater improvements between months 1 and 4. Range of motion declined in this group between months 5 and 10 and then gradually improved and slightly surpassed that of the women with BCS. The women who had a surgical drain placed at the time of surgery demonstrated greater reductions in shoulder flexion at 1 month with gradual and consistent improvements to month 6 at which time trajectories were similar for women with and without drain placement. Table 4 presents estimates of the unconditional cubic change model for grip strength. The trajectory for grip strength over the 12-month postoperative period illustrates a small increase in grip strength between months 1 and 4 (Supplemental Figure 2A , http://links.lww.com/PHM/A193). The trajectory plateaus between months 4 and 6 with a minimal decline between months 6 and 10 followed by a small increase.
Grip Strength
As the final model in Table 4 and Supplemental Figures 2B through D (http://links.lww.com/PHM/A193) shows, 3 variables predicted interindividual differences in the intercept for grip strength. Older age, having a lower KPS score, and having poorer preoperative grip strength were associated with decreased grip strength at the 1-month assessment. The only variable that predicted interindividual differences in the grip strength trajectory was receipt of adjuvant CTX during the first year (Supplemental Figure 2E , http://links.lww.com/PHM/A193). Women who had adjuvant CTX demonstrated poorer grip strength, with a progressively greater decline between months 3 and 10. Table 4 presents the estimates of the unconditional cubic change model for the mean functional interference score related to breast pain. As Figure 4A shows, the trajectory for the average functional interference score over the 12-month postoperative period shows improved scores between months 1 and 5, gradual worsening of the scores between 
Functional Interference Related to Breast Pain
FIGURE 4
A, Trajectory for average breast pain interference scores over the 12-month postoperative period using an unconditional model. BYF, Adjusted change curves of average breast pain interference scores over 12 months by age (older/younger calculated as 1 SD above/below the mean preoperative age; B), ethnicity (white or nonwhite; C), KPS score) score (higher/lower calculated as 1 standard deviation above/below the mean preoperative KPS score; D), SCQ score (higher/lower calculated as 1 standard deviation above/below the mean preoperative SCQ score; E), and stage of disease (higher/lower; F).
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Arm Function After Breast Cancer Treatment months 6 and 10, and then improvements again from months 10 to 12, with the lowest scores (reflecting least interference) at months 5 and 12. As the final model in Table 4 and Figures 4B through F and 5A and B shows, 7 variables predicted interindividual differences in the intercept for breast pain functional interference. Younger age, being nonwhite, having a lower KPS score, a higher Self-Administered Comorbidity Questionnaire score, a higher disease stage at the time of diagnosis, having a higher preoperative breast pain functional interference score, and having reconstruction at the time of surgery were associated with higher breast pain functional interference scores at the 1-month assessment.
As Figures 4C, and 5C through 5E show, the 4 variables that predicted interindividual differences in the trajectories of interference scores over the 12-month postoperative period were ethnicity, type of breast cancer surgery, placement of a surgical drain, and re-excision during the first year. Nonwhite women demonstrated higher interference scores than white women across all assessments, with the largest differences seen between months 1 to 3 and 8 to 10, when both groups demonstrated relatively higher scores. Despite similar scores at the 1-month assessment, women who had mastectomy demonstrated a greater improvement (drop) in the interference scores compared to women with BCS, until month 4. At this time, the scores for women after mastectomy increased and were notably higher than for women with BCS, whose scores had essentially plateaued. This trajectory was similar to that seen for the women who did not have a drain placed at the time of surgery. Scores for the women who did and did not undergo re-excision were the same at 1 month, but scores were higher for the women who underwent re-excision in each subsequent assessment until month 12 at which time scores were similar. Table 5 provides a summary of the predictors for each of the outcomes, for comparative purposes.
Summary of Predictors
DISCUSSION
To our knowledge, this study is the first to use HLM to model trajectories of UE function after breast cancer treatment and to evaluate the impact of preoperative function on postoperative function. Since one of the goals of this analysis was to identify risk factors for impaired UE function, the discussion is organized by predictors: treatment-related predictors, demographic and clinical predictors, and finally, modifiable preoperative predictors.
Treatment-Related Predictors
The treatment predictors of postoperative function were type of surgery, ALND, breast reconstruction at time of surgery, placement of a surgical drain, and breast re-excision during the year after surgery. Only 20% of the women in this study underwent mastectomy, lower than national trends. 24, 25 Compared to BCS, receipt of mastectomy was associated with significant decrements in shoulder abduction at 1 month, as well as across the 12-month trajectories for abduction, flexion, and breast pain interference with function. At the 1-month assessment, women who had a mastectomy demonstrated markedly less abduction compared to women who had BCS, but by month 12, abduction was similar between the groups. Reductions of more than 20 degrees are associated with loss of UE function 22 and reductions in QOL. 26, 27 Women who had a mastectomy had approximately 30 degrees less abduction ROM at 1 month and did not regain this motion until 5 months postoperatively. In contrast, mastectomy was not associated with 1-month differences in flexion ROM but only with differences in the trajectories of flexion over the first 6 months. However, differences in flexion between mastectomy and BCS groups were not clinically meaningful at less than 5 degrees at all time points. Our findings contrast with those from a prospective longitudinal study 6 that found an association between mastectomy and loss of flexion ROM (P = 0.015) but not with loss of abduction (P = 0.058) at 12 months after breast cancer surgery.
Although the type of surgery did not predict breast pain interference scores at the 1-month assessment, it did predict the 12-month trajectory for these scores, which were highly variable for the women who had mastectomy. Of the 78 women who had a mastectomy, 47% had reconstruction between months 1 and 12, compared to only 3% of women with BCS (P G 0.001), which may have contributed to the greater variability in the breast pain interference scores in women with mastectomy.
Thirty-seven percent of the women in this study had an ALND. Having an ALND versus sentinel lymph node biopsy (SLNB) was associated with 11 degrees less abduction at 1 month. Whereas this change meets the criteria for a minimal detectable change in shoulder abduction ROM, between-group differences at 12 months were not clinically meaningful. 28 Differences in shoulder flexion were not clinically meaningful (G3 degrees) at any time point. 28 Our findings of limited shoulder abduction are similar to previous reports 6, 29 that found an association between ALND and limitations in shoulder ROM. In one study, 30 having an ALND was associated with statistically significant reductions in shoulder ROM at 1 year. At the 7-year follow-up, 1 restriction in ROM, particularly in abduction, persisted in women who had ALND compared to those who had a SLNB.
In another prospective study, 8 women who had an ALND had more UE impairments at 2.5 years than women who had SLNB. However, the differences in ROM between the groups at 2.5 years were not statistically significant. Placement of a surgical drain was required for 94% of the women who had mastectomy and 27% of the women who had BCS. Drains are an important component of surgical management to prevent accumulation of fluid. Women who had a drain placed during surgery had 15 degrees less shoulder flexion at 1 month than the women who did not require a surgical drain. However, at 6 months, this difference was negligible. It is possible that restriction in shoulder flexion could result from soft tissue changes at the lateral thorax and chest wall. Interestingly, beginning at month 5, women who had a surgical drain demonstrated better functional interference scores. Of the women who did not have a surgical drain, 77% of them received radiation therapy during the first year (compared to 61% of the women who had a drain; P G 0.001) and 35% underwent re-excision (compared to 23% of the women who had a surgical drain, P = 0.01). This finding suggests that women who have surgical drains require referral to physical therapy.
Twenty-two percent of the patients had breast reconstruction at the time of surgery. This procedure was associated with higher interference ratings at 1 month, and these differences were consistent across time and persisted even at 12 months. Not surprisingly, breast re-excision during the first year (30.1% of women) was associated with higher interference scores between months 1 and 12. However, by the 12-month assessment, these scores were only slightly higher in the women who required re-excision.
In this study, 20% of the women received neoadjuvant CTX. These women had 5 degrees less shoulder abduction ROM at all of the postoperative assessments than the women who did not receive neoadjuvant CTX. In addition, neoadjuvant CTX predicted only minimal reductions in shoulder flexion at 1 month (G4 degrees). Receipt of adjuvant CTX (20%) predicted the 12-month trajectories for shoulder abduction and flexion ROM. These differences were not clinically meaningful at any point and were essentially nil by month 12. However, differences in trajectories for grip strength between women who did and did not receive adjuvant CTX were more pronounced. Women receiving adjuvant CTX demonstrated less grip strength beginning at month 3. Even by month 12, although increasing, grip strength did not reach the values for women who had not received CTX. This finding may be related to neuropathic pain associated with CTX agents or musculoskeletal complaints associated with hormonal therapies. 9
Demographic and Clinical Predictors
The need for more aggressive treatment may have contributed to ethnic differences in shoulder abduction ROM and breast pain interference scores. More nonwhite women than white women had stage II to IV cancer (51% compared to 40%; P = 0.03) and more had an ALND (44% versus 33%; P = 0.03). Nonwhite women consistently had approximately 8 degrees less shoulder abduction ROM and had higher breast pain interference scores than white women across all postoperative assessments. Higher stage of disease was also associated with higher breast pain interference scores at the 1-month assessment.
With regard to age, younger women had higher pain interference scores across all time points. However, no age differences were found in the trajectories of breast pain interference scores. This finding is consistent with previous results from our group 31 and others, 32 that younger patients are at higher risk for more severe persistent pain after breast cancer surgery.
In addition, older women had weaker grip at the 1-month assessment. Normative values for grip strength for women between the ages of 55 and 59 are reported as 27.2 kg (left), and 29.9 kg (right). 33 Between 50 and 54 years, normative values are 28.8 kg (right) and 30.9 kg (left). The mean age for the women in this study was 54.9 years, and the mean preoperative grip strength was 23.8 kg and 23.6 kg on the unaffected and affected sides, respectively. Our results are lower than these healthy norms across all time points. Since poorer grip strength is associated with higher risk for future disability, 34, 35 grip strength may provide a simple and useful postoperative screening tool.
At the time of enrollment, 23.7% of the women in this study reported living alone. While living alone did not predict differences in shoulder ROM at 1 month, it did predict the trajectories for both shoulder abduction and flexion. Whereas differences in trajectories for abduction ROM were more marked, the patterns were similar. Women who lived alone demonstrated slightly greater improvements in ROM until month 5; they had gradual declines in ROM. By month 12, ROM was essentially the same between women who did and did not live alone. It is possible that women who lived alone used their arm more for activities of daily living, which resulted in early improvement in their ROM, but this finding needs to be verified in future studies.
The KPS scale is organized in 10-unit increments, with 100 representing normal performance, 90 being able to carry on normal activity, 80 being normal activity with effort, 70 being able to care for self, and so on. Although differences in grip strength were associated with KPS scores, these differences were small. The difference in grip strength between women who were 1 SD above and 1 SD below the mean preoperative KPS scores was 0.88 kg at 1 month. This difference represents a small standardized effect size of 0.15, which was consistent across all assessments. Differences in breast pain functional interference scores at 1 month were also associated with KPS scores. Breast pain functional interference scores were very low before surgery, indicating little interference with function. However, at 1 month and over the year after surgery, breast pain interference scores were consistently higher (greater interference) in women with lower preoperative KPS scores. Better self-report of performance preoperatively is associated with less functional interference due to breast pain postoperatively. Higher levels of comorbidity were associated with worse breast pain interference scores 1 month after surgery. These differences were consistent and persistent across time.
Modifiable Preoperative Predictors
Enrollment values for shoulder abduction ROM, shoulder flexion ROM, grip strength, and breast pain functional interference score each predicted their respective functional outcomes at 1 month after surgery but did not predict the trajectories of change over the subsequent assessments. Not surprisingly, lower preoperative function predicted lower postoperative function.
Preoperative ROM was a strong predictor of 1 month postoperative ROM for both abduction and flexion. Each degree more of preoperative ROM was associated with 0.64 degree more abduction ROM at 1 month and 0.61 degree more flexion ROM at 1 month. To further evaluate this association, ROM outcomes were dichotomized using the convention of 1 SD above and below the mean preoperative ROM values. One month postoperatively, the women who were 1 SD or greater (20.2 degrees) below the preoperative mean for abduction demonstrated an average 28 degrees less abduction than the women who were 1 SD above the mean. Women who were Q1 SD or greater (10.3) below the preoperative mean for flexion demonstrated an average of 12 degrees less flexion postoperatively than the women who were 1 SD above the preoperative mean. Patients with less ROM before surgery had greater reductions after surgery, which did not return to the presurgical levels even by month 12.
Not surprisingly, preoperative grip strength predicted 1-month postoperative grip strength. Additionally, lower grip strength scores at 1 month were seen in older women and in women with lower KPS scores. The decline in mean grip strength from presurgery to 1 month after surgery was very small and not clinically meaningful, and grip strength remained fairly stable over time. Although differences in grip strength reached statistical significance, they did not reach the threshold for a clinically meaningful difference 36 and may be accounted for, in part, by hand dominance.
Upper extremity function was measured subjectively through the breast pain functional interference score. Women with higher preoperative breast pain functional interference scores (greater interference) had consistently higher postoperative breast pain functional interference scores at all assessments.
Finally, engaging in exercise before surgery was associated with greater shoulder flexion ROM at 1 month, which persisted over the rest of the year. However, the difference was only 3 degrees, which is not clinically meaningful.
Clinical Implications
Some decline in UE function after breast cancer surgery is expected. Findings from this study suggest that both measures of shoulder ROM were impaired during the first year after breast cancer treatment. We observed a modest decline in shoulder ROM between months 5 and 10, noted consistently in the trajectories of both abduction and flexion. Although, we do not know why this transient decline in ROM occurred, this finding warrants replication and investigation in future studies.
Of note, for some women, these impairments persisted at 12 months. Moreover, consistent with a previous report, 1 nearly 17% of the women in our study had a 20-degree or greater reduction in shoulder abduction ROM on their affected relative to their unaffected side at 12 months, compared to only 8% preoperatively. A reduction in shoulder abduction ROM of 20 degrees or greater is associated with greater difficulty with household activities and hobbies, with subjective reports of disability, 22 and with decrements in QOL. 26, 27 The risk factors associated with decrements in shoulder abduction ROM found in this study can assist clinicians to identify high-risk patients so that interventions (eg, education, exercise, manual therapy, and pain management) can be initiated early in the preoperative or perioperative period.
Limitations in ROM, reduced grip strength, functional interference due to pain, and decreased participation in exercise are all targetable, modifiable risk factors for postoperative decrements in UE function. Early identification and treatment of physical impairments may mitigate their negative impact on function and QOL after cancer treatment. Currently, oncology rehabilitation follows an impairmentbased model, in which treatment is initiated once impairments are identified after cancer treatment. 37 In contrast, Bprehabilitation[ is initiated after the cancer diagnosis but before cancer treatment begins. Prehabilitation includes surveillance to identify impairments or risk factors for future impairments, and implementation of education or treatments to improve existing impairments or promote risk reduction for future impairments. 37 Preoperative assessments and preoperative or early interventions have shown promising results in improving outcomes and decreasing costs, 5,38 but additional high-quality studies are needed.
Several study limitations deserve mention. First, 24% of the women in our study received physical therapy during the first year after breast cancer surgery. Patients were asked if at any time during the study they received physical therapy, which was treated as a dichotomous, nonvarying covariate. We did not have detailed information on the specific physical therapy procedures that the patient received before and after surgery. Although not a significant predictor for any of the study outcomes, it is possible that patients with greater symptomatic dysfunction sought out physical therapy, which may have influenced the study outcomes. Second, we did not evaluate other UE strength outcomes, such as shoulder strength, nor did we include assessment of functional shoulder ROM during task performance. Third, we did not include time-varying covariates in our model because the primary goal of this study was to understand the impact of demographic and clinical characteristics, and preoperative function, on postoperative functional outcomes. Finally, whereas we relied on previous literature and clinical experience to determine relevant predictors, additional predictors warrant evaluation in future studies.
Despite these limitations, this large prospective longitudinal study provides new insights on the impact of preexisting functional limitations on postsurgical outcomes. Moreover, the use of HLM enabled an evaluation of predictors of interindividual differences of the trajectories of these outcomes over the 12 months after surgery. The identification and assessment of modifiable risk factors, as well as the initiation of preemptive or prompt postoperative interventions, may reduce the need for more aggressive and costly rehabilitation after breast cancer surgery. 5, 6 This hypothesis warrants evaluation in future studies. 
